ACADIA Pharmaceuticals Inc.
ACAD
$16.12
-$0.50-3.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 755.99M | 565.33M | 500.94M | 470.52M | 438.87M |
| Total Receivables | 104.70M | 110.36M | 110.39M | 100.08M | 102.35M |
| Inventory | 21.95M | 61.04M | 71.53M | 61.94M | 35.82M |
| Prepaid Expenses | 55.68M | 51.55M | 46.06M | 42.76M | 39.09M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 938.32M | 788.28M | 728.92M | 675.30M | 616.13M |
|
|
|||||
| Total Current Assets | 938.32M | 788.28M | 728.92M | 675.30M | 616.13M |
| Net Property, Plant & Equipment | 50.79M | 48.24M | 56.53M | 58.65M | 56.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 119.78M | 105.52M | 107.86M | 110.20M | 65.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 78.87M | 34.83M | 20.79M | 10.95M | 10.87M |
| Total Assets | 1.19B | 976.87M | 914.10M | 855.10M | 748.96M |
|
|
|||||
| Total Accounts Payable | 16.19M | 19.08M | 19.88M | 19.33M | 17.54M |
| Total Accrued Expenses | 266.46M | 236.33M | 227.92M | 221.23M | 197.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.96M | 8.95M | 10.47M | 10.45M | 9.41M |
| Total Finance Division Other Current Liabilities | 102.26M | 79.58M | 79.58M | 79.58M | 29.58M |
| Total Other Current Liabilities | 102.26M | 79.58M | 79.58M | 79.58M | 29.58M |
| Total Current Liabilities | 394.87M | 343.95M | 337.85M | 330.60M | 254.25M |
|
|
|||||
| Total Current Liabilities | 394.87M | 343.95M | 337.85M | 330.60M | 254.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.04M | 40.42M | 47.19M | 49.19M | 47.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.06M | 15.32M | 12.36M | 11.27M | 15.15M |
| Total Liabilities | 454.96M | 399.69M | 397.40M | 391.06M | 317.20M |
|
|
|||||
| Common Stock & APIC | 2.94B | 2.92B | 2.90B | 2.88B | 2.86B |
| Retained Earnings | -2.20B | -2.35B | -2.38B | -2.41B | -2.43B |
| Treasury Stock & Other | 292.00K | 858.00K | -339.00K | -229.00K | 24.00K |
| Total Common Equity | 732.79M | 577.18M | 516.70M | 464.04M | 431.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 732.79M | 577.18M | 516.70M | 464.04M | 431.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 732.79M | 577.18M | 516.70M | 464.04M | 431.76M |
|
|
|||||
